1. Home
  2. Labeler Index
  3. Allergan, Inc.
  4. 0023-3348
  5. NDC Package Code: 0023-3348-07 Ozurdex

NDC Package 0023-3348-07 Ozurdex

Dexamethasone Implant Intravitreal - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0023-3348-07
Package Description:
1 POUCH in 1 CARTON / 1 IMPLANT in 1 POUCH
Product Code:
0023-3348
Proprietary Name:
Ozurdex
Non-Proprietary Name:
Dexamethasone
Substance Name:
Dexamethasone
Usage Information:
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.
11-Digit NDC Billing Format:
00023334807
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 854177 - dexAMETHasone 0.7 MG Intravitreal Drug Implant
  • RxCUI: 854177 - dexamethasone 0.7 MG Drug Implant
  • RxCUI: 854177 - dexamethasone 0.7 MG Intraocular Drug Implant
  • RxCUI: 854181 - Ozurdex 0.7 MG Intravitreal Drug Implant
  • RxCUI: 854181 - dexamethasone 0.7 MG Drug Implant [Ozurdex]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Allergan, Inc.
    Dosage Form:
    Implant - A material containing drug intended to be inserted securely of deeply in a living site for growth, slow release, or formation of an organic union.
    Administration Route(s):
  • Intravitreal - Administration within the vitreous body of the eye.
    • Active Ingredient(s):
  • DEXAMETHASONE .7 mg/1
    • Pharmacologic Class(es):
  • Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
  • Corticosteroid - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA022315
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    09-01-2009
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0023-3348-07 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00023334807J7312Dexamethasone intra implant0.1 MG0.7177

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0023-3348-081 POUCH in 1 CARTON / 1 IMPLANT in 1 POUCH

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0023-3348-07?

    The NDC Packaged Code 0023-3348-07 is assigned to a package of 1 pouch in 1 carton / 1 implant in 1 pouch of Ozurdex, a human prescription drug labeled by Allergan, Inc.. The product's dosage form is implant and is administered via intravitreal form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 0023-3348 included in the NDC Directory?

    Yes, Ozurdex with product code 0023-3348 is active and included in the NDC Directory. The product was first marketed by Allergan, Inc. on September 01, 2009 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0023-3348-07?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0023-3348-07?

    The 11-digit format is 00023334807. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20023-3348-075-4-200023-3348-07